The International Conference on Advanced Technologies and Treatments of Diabetes (ATTD-ASIA 2024) was grandly held in Singapore from November 18 to 20, 2024. This conference brought together numerous experts and scholars in the field of diabetes to discuss the latest advancements in diabetes technology and future treatment directions. Sinocare showcased its innovative products and technologies, including the Sinocare Continuous Glucose Monitoring System (CGM), traditional Blood Glucose Monitoring (BGM), and Point-of-Care Testing (POCT), demonstrating its latest achievements in the field of diabetes management.

Dr. Warren Lee, a renowned pediatric endocrinologist from Singapore, highly praised Sinocare's blood glucose monitoring devices and digital solutions.

Professor Zhou Yijun from the Chinese University of Hong Kong, in her presentation "Lifestyle Intervention and CGM for Prediabetes," delved into the crucial role of technological means in diabetes prevention. Professor Zhou also showcased Sinocare's digital diabetes management model, which integrates biosensing, S.IoT, smart healthcare, and healthy lifestyle guidance. This model uses wearable devices to monitor patients' health data in real-time and employs artificial intelligence for in-depth analysis, providing patients with personalized health management plans.

Sinocare's impressive presence at ATTD-ASIA 2024 not only showcased its innovative technologies and solutions in diabetes management but also provided attendees with valuable opportunities for exchange and learning.